Key result
Cardiomyocyte-specific deletion of GSK-3beta protected against post-MI remodeling, preserving left ventricular function at up to 8 weeks, and promoted stress-induced cardiomyocyte proliferation.
Why the study?
Does inducible, cardiomyocyte-specific deletion of GSK-3beta improve post-MI remodeling and cardiomyocyte proliferation in adult mice?
Does inducible, cardiomyocyte-specific deletion of GSK-3beta improve post-MI remodeling and cardiomyocyte proliferation in adult mice?
Answers are grounded in this paper and cite their sources.
Cardiomyocyte-specific deletion of GSK-3beta in adult mice protects against post-MI remodeling and promotes stress-induced cardiomyocyte proliferation, suggesting a potential therapeutic target for cardiac regeneration.
RATIONALE: Numerous studies have proposed that glycogen synthase kinase (GSK)-3beta is a central regulator of the hypertrophic response of cardiomyocytes. However, all of this work has relied on overexpression of GSK-3beta, expression of constitutively active mutants, or small molecule inhibitors with documented off-target effects. Genetic loss of function approaches have not been used in the adult mouse because germ-line deletion of GSK-3beta is embryonic-lethal. OBJECTIVE: This study was designed to define the role played by GSK-3beta in pressure overload (PO)-induced hypertrophy and remodeling following myocardial infarction (MI). METHODS AND RESULTS: We used a mouse model that allows inducible, cardiomyocyte-specific deletion of GSK-3beta in the adult knockout. Surprisingly, we find that knockout mice exposed to PO induced by thoracic aortic constriction exhibit a normal hypertrophic response. Thus, in contrast to virtually all prior published studies, GSK-3beta appears to play at most a minor role in the hypertrophic response to PO stress. However, GSK-3beta does regulate post-MI remodeling because the GSK-3beta knockouts had less left ventricular dilatation and better-preserved left ventricular function at up to 8 weeks post-MI despite demonstrating significantly more hypertrophy in the remote myocardium. Deletion of GSK-3beta also led to increased cardiomyocyte proliferation following PO and MI. CONCLUSIONS: Deletion of GSK-3beta protects against post-MI remodeling and promotes stress-induced cardiomyocyte proliferation in the adult heart. These studies suggest that inhibition of GSK-3beta could be a strategy to both prevent remodeling and to promote cardiac regeneration in pathological states.
No takes yet. Share an insight, caveat, or question.
Woulfe et al. (2010) studied Myocardial Infarction and Pressure Overload. Cardiomyocyte-specific deletion of GSK-3beta was evaluated on Hypertrophic response, post-MI remodeling, and cardiomyocyte proliferation. Cardiomyocyte-specific deletion of GSK-3beta protected against post-MI remodeling, preserving left ventricular function at up to 8 weeks, and promoted stress-induced cardiomyocyte proliferation.
Synapse has enriched 10 related papers. Consider them for comparative context: